BPS - ADVANCE THE DEVELOPMENT OF V920, A VACCINE AGAINST EBOLA VIRUS USING A RECOMBINANT VESICULAR STOMATITIS VIRUS VECTOR. IGF::OT::IGF
$65,103,309
| Recipient | MERCK SHARP & DOHME LLC UEI FCFDA78HKKG2 |
|---|---|
| Award ID | HHSO100201600031C |
| Award amount | $65,103,309 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY |
| PSC | AN13 |
| Start date | Aug 29, 2016 |
| End date | Sep 30, 2024 |
| Place of performance | AMES, IA |
| Record updated | Sep 4, 2025 |
View the official award record
More awards won by MERCK SHARP & DOHME LLC
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Department of Veterans Affairs · $5,837,161,580 · Jun 1, 2025
VACCINES FOR CHILDREN
Department of Health and Human Services · $4,481,646,300 · Apr 1, 2026
VACCINES FOR CHILDREN FY25
Department of Health and Human Services · $4,382,496,700 · Apr 1, 2025
2024-2025 VACCINES FOR CHILDREN
Department of Health and Human Services · $4,079,096,100 · Apr 1, 2024
VACCINES FOR CHILDREN
Department of Health and Human Services · $3,942,689,200 · Apr 1, 2023
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids